« Dr. Raj Manglik, Professor of Mechanical Engineering and Director of the Thermal Fluids and Thermal Processing Laboratory, University of Cincinnati, 6-14-07 | Main | Dr. Michael Liebschner, Assistant Professor of Bioengineering, and Dr. Lin Zhong, Assistant Professor of Electrical and Computer Engineering, Rice University, 6-21-07 »
June 14, 2007
Dr. Eva Surmacz, Associate Professor of Biology, College of Science and Technology, Temple University, and Director of the Obesity and Cancer Program, Sbarro Health Research Organization, 6-14-07
Dr. Eva Surmacz is an internationally recognized expert in cancer biology. The work in Dr. Surmacz's laboratory, in addition to projects related to the link between obesity and cancer, includes studies on crosstalk between growth factor and steroid receptors in cancer progression and development of anti-cancer targeted strategies.
A native of Poland, Dr. Surmacz joined Temple’s faculty and the Sbarro Institute for Cancer Research and Molecular Medicine in 2004 from Thomas Jefferson University’s Kimmel Cancer Center. She was originally introduced to Temple in 1980 as a summer student in the School of Medicine’s department of pathology. She returned as a visiting research fellow at the School of Medicine from 1984 to 1986 and later earned her doctorate in biochemistry through a joint program between Temple and the Polish Academy of Sciences in Warsaw in 1988.
Dr. Surmacz joined the faculty at Jefferson University in 1993 after serving as a senior scientist at the Biotechnology Center in Warsaw and a postdoctoral fellow at Boston University and Jefferson. As an independent investigator, she has had research funded over the past 12 years by the National Institutes of Health, the Department of Defense Breast Cancer Research Program, several private foundations and organizations, and the pharmaceutical industry.
The Sbarro Health Research Organization (SHRO) funds innovative and dedicated clinicians, molecular biologists, geneticists and chemists who seek to diagnose and cure cancer and cardiovascular conditions by identifying and studying the underlying molecular mechanisms of these diseases. The Organization also funds work on the links between obesity and cancer along with a new molecular therapeutics program that will spur the application of the newest discoveries to useful drug or diagnostic therapies for a wide range of diseases.
Posted by David Lemberg at June 14, 2007 08:19 AM Return to SCIENCE AND SOCIETY home page